The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.
BTIG analyst Marvin Fong maintained a Buy rating on Mercadolibre (MELI – Research Report) today and set a price target of $2,500.00. The ...
In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...
When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.
Stocks were mostly lower on Thursday after a disappointing business forecast from retail giant Walmart. Here, we look at the ...
TipRanks on MSN4d
NeoGenomics price target lowered to $17 from $18 at BTIGBTIG lowered the firm’s price target on NeoGenomics (NEO) to $17 from $18 and keeps a Buy rating on the shares. Q4 results came in light “at an ...
Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback